In vitro senescence models for human T lymphocytes

By Pawelec G.   Adibzadeh M.   Rehbein A.   Hahnel K.   Wagner W.   Engel A.  

Vaccine, Vol. 18, Iss. 16, 2000-02 ,pp. : 1666-1674

Elsevier

Access to resources Recommend Favorite

Partial characterization of lacticin NK24, a newly identified bacteriocin of Lactococcus lactis NK24 isolated from Jeot-gal

By Lee N.-K.   Paik H.-D.  

Food Microbiology, Vol. 18, Iss. 1, 2001-02 ,pp. : 17-24

Elsevier

Access to resources Recommend Favorite

Human T-cells recognise N-terminally Fmoc-modified peptide

By Mannering S.I.   Purcell A.W.   Honeyman M.C.   McCluskey J.   Harrison L.C.  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3638-3646

Elsevier

Access to resources Recommend Favorite

Activation and functional capacity of human neonatal CD4 T-cells

By Reen D.J.  

Vaccine, Vol. 16, Iss. 14, 1998-08 ,pp. : 1401-1408

Elsevier

Access to resources Recommend Favorite

Application of murine T-T hybridoma cells to in vitro potency assay of human synthetic peptide vaccines

By Sheue C.T.Y.   Nag B.  

Vaccine, Vol. 14, Iss. 14, 1996-10 ,pp. : 1313-1321

Elsevier

Access to resources Recommend Favorite